The International Academy of Clinical Research (IAoCR) has now released its draft GxP Training Guidelines for public consultation following initial review and feedback from over 35 not-for-profit and membership organisations around the world.
Over 60 training and quality assurance personnel have already requested a copy of the draft GxP Training Guidelines which are being made freely available by the IAoCR in order to involve the widest number of interested parties from within the clinical research industry.
As CEO at IAoCR, Jacqueline Johnson North explains: “We have always felt that it is crucial to engage the entire industry in order to create the most cohesive, relevant set of GxP Training recommendations possible. The more people who review this document and provide feedback, the more valuable it will be to all of us. We would like these training guidelines to be applicable to all members of the industry across all sectors and we actively encourage everyone to get involved. We are very pleased with the interest shown to date and hope this accurately reflects the level of commitment from the industry.”
Following the launch of this initiative, executives from the IAoCR have been invited to speak at a number of conferences later this year and on into 2013. Jacqueline will be speaking at the European Training Conference in Lisbon in April 2013 and the IAoCR’s Principal Director, Martin Robinson will be speaking at the French Biomedical Data Management Association conference in Paris in November 2012.
The GxP Training Guidelines have been produced by the International Academy of Clinical Research with input from an independent taskforce of industry experts from the international clinical research community. The aim of the Guidelines is to provide best practice recommendations for the training life-cycle to enable organisations to be able to demonstrate individuals’ competence. The document contains minimum requirements for best practice in training and will be used to help introduce consistent training standards across the industry. It is hoped that the guidelines will be voluntarily adopted across the industry and that this will provide a global framework for best practice.
To receive a copy of the draft Guidelines and information on how to provide feedback complete the webform on www.iaocr.com/gxpt The deadline for feedback is 30 September 2012. After this time, the guidelines will be finalised ready for publication in October 2012.
For more information, please visit www.iaocr.com.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.